PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.02%
Positive revenue growth while ADI is negative. John Neff might see a notable competitive edge here.
7.03%
Positive gross profit growth while ADI is negative. John Neff would see a clear operational edge over the competitor.
10.15%
EBIT growth 50-75% of ADI's 14.46%. Martin Whitman would suspect suboptimal resource allocation.
10.59%
Operating income growth at 50-75% of ADI's 14.46%. Martin Whitman would doubt the firm’s ability to compete efficiently.
2.86%
Net income growth under 50% of ADI's 41.64%. Michael Burry would suspect the firm is falling well behind a key competitor.
3.62%
EPS growth under 50% of ADI's 36.71%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
3.70%
Diluted EPS growth under 50% of ADI's 35.90%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.61%
Share reduction while ADI is at 0.35%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.80%
Reduced diluted shares while ADI is at 0.16%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-0.21%
Dividend reduction while ADI stands at 6.56%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
64.21%
OCF growth at 75-90% of ADI's 84.85%. Bill Ackman would demand better working capital management or cost discipline.
70.86%
FCF growth 50-75% of ADI's 104.20%. Martin Whitman would see if structural disadvantages exist in generating free cash.
61.96%
10Y revenue/share CAGR at 50-75% of ADI's 82.69%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
48.84%
5Y revenue/share CAGR at 50-75% of ADI's 90.51%. Martin Whitman would worry about a lagging mid-term growth trajectory.
31.55%
3Y revenue/share CAGR at 50-75% of ADI's 55.57%. Martin Whitman would question if the firm lags behind competitor innovations.
375.35%
10Y OCF/share CAGR 1.25-1.5x ADI's 266.88%. Bruce Berkowitz would confirm if the firm's long-term capital allocation yields better cash returns.
205.86%
5Y OCF/share CAGR above 1.5x ADI's 136.49%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
135.70%
3Y OCF/share CAGR above 1.5x ADI's 76.30%. David Dodd would confirm if the firm is quickly gaining an operational edge over the competitor.
222.83%
Net income/share CAGR above 1.5x ADI's 123.76% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
140.33%
5Y net income/share CAGR above 1.5x ADI's 91.70%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
113.67%
3Y net income/share CAGR above 1.5x ADI's 56.15%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
43.90%
Below 50% of ADI's 260.22%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
8.47%
Below 50% of ADI's 96.98%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
10.29%
Below 50% of ADI's 80.00%. Michael Burry suspects a serious short-term disadvantage in building book value.
520.27%
10Y dividend/share CAGR above 1.5x ADI's 166.19%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
121.41%
5Y dividend/share CAGR above 1.5x ADI's 41.73%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
81.19%
3Y dividend/share CAGR above 1.5x ADI's 20.51%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
6.67%
AR growth well above ADI's 7.02%. Michael Burry fears inflated revenue or higher default risk in the near future.
2.85%
We show growth while ADI is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
5.83%
Positive asset growth while ADI is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
0.54%
Under 50% of ADI's 1.94%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
24.23%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-0.26%
Our R&D shrinks while ADI invests at 0.30%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
1.85%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.